These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 2139826)

  • 1. [Therapeutic use of glutathione].
    Del Nero E; De Lorenzi E; Granata L; Torre E; Cavagnaro A
    Clin Ter; 1990 Feb; 132(3):167-71. PubMed ID: 2139826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the changes in some laboratory parameters in liver disease patients treated with Toxepasi Complex].
    Lenzi S
    Minerva Med; 1976 Sep; 67(46):2961-74. PubMed ID: 967362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity of blood antioxidant enzymes in chronic liver damage].
    Matiushin BN; Loginov AS; Iakimchuk GN; Tkachev VD
    Vopr Med Khim; 1995; 41(4):54-6. PubMed ID: 8571591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Controlled clinical trial of 5(4)-amino-4(5)-imidazole carboxyamide ureidosuccinate, a new hepatic therapeutic agent stimulating liver regeneration and protein anabolism].
    Busin S; Micheli PL; Sovera A
    Clin Ter; 1977 Dec; 83(5):483-529. PubMed ID: 343971
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation between plasma and hepatic phosphatidylcholine hydroperoxide, energy charge, and total glutathione content in ischemia reperfusion injury of rat liver.
    Suzuki M; Fukuhara K; Unno M; Htwe T; Takeuchi H; Kakita T; Matsuno S
    Hepatogastroenterology; 2000; 47(34):1082-9. PubMed ID: 11020884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of the heptoprotective agent LIV 52 on liver damage].
    Kaláb M; Krechler T
    Cas Lek Cesk; 1997 Dec; 136(24):758-60. PubMed ID: 9511259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glutathione in the treatment of chronic fatty liver diseases].
    Dentico P; Volpe A; Buongiorno R; Grattagliano I; Altomare E; Tantimonaco G; Scotto G; Sacco R; Schiraldi O
    Recenti Prog Med; 1995; 86(7-8):290-3. PubMed ID: 7569285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of domestic glutathione on the alcoholic liver disease].
    Zhang Q; Guo S; Hu D; He N; Zhang J; Zhong S; Chen Y; Zhang D
    Zhonghua Gan Zang Bing Za Zhi; 2000 Aug; 8(4):239-40. PubMed ID: 10951629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experience with the oral liver-therapeutic agent Hepavis].
    Bayazid A; Gerhard W
    Med Welt; 1976 Nov; 27(46):2248-9. PubMed ID: 794616
    [No Abstract]   [Full Text] [Related]  

  • 10. Aqueous garlic extract alleviates ischaemia-reperfusion-induced oxidative hepatic injury in rats.
    Sener G; Sehirli O; Ipçi Y; Ercan F; Sirvanci S; Gedik N; Yeğen BC
    J Pharm Pharmacol; 2005 Jan; 57(1):145-50. PubMed ID: 15639002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical significance of the enzymatic system utilizing active forms of oxygen in chronic liver diseases].
    Loginov AS; Matiushin BN
    Ter Arkh; 1994; 66(4):65-8. PubMed ID: 8016735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major extended hepatic resections in diseased livers using hypothermic protection: preliminary results from the first 12 patients treated with this new technique.
    Hannoun L; Delrivière L; Gibbs P; Borie D; Vaillant JC; Delva E
    J Am Coll Surg; 1996 Dec; 183(6):597-605. PubMed ID: 8957462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled trial of steroid therapy in massive hepatic necrosis.
    Ware AJ; Jones RE; Shorey JW; Combes B
    Am J Gastroenterol; 1974 Aug; 62(2):130-3. PubMed ID: 4606110
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations.
    Myers RP; Cerini R; Sayegh R; Moreau R; Degott C; Lebrec D; Lee SS
    Hepatology; 2003 Feb; 37(2):393-400. PubMed ID: 12540790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of levamisole, an immune controlling agent in various clinical conditions mainly liver diseases (author's transl)].
    Miyake M
    Fukuoka Igaku Zasshi; 1981 Jun; 72(6):368-78. PubMed ID: 6975743
    [No Abstract]   [Full Text] [Related]  

  • 16. [The efficacy of pharmacotherapy in patients with chronic liver pathology and the function of the antioxidant defense enzymes].
    Loginov AS; Matiushin BN; Iakimchuk GN
    Ter Arkh; 1995; 67(2):3-6. PubMed ID: 7725254
    [No Abstract]   [Full Text] [Related]  

  • 17. [Plasma selenium concentration, glutathione peroxidase and glutathione S-transferase activities in patients with chronic liver diseases].
    Czuczejko J; Halota W; Zachara BA; Staubach-Topczewska E
    Pol Merkur Lekarski; 2002 Oct; 13(76):312-5. PubMed ID: 12557439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glutathione chemoprotection therapy against CDDP-induced neurotoxicity in patients with invasive bladder cancer].
    Sumiyoshi Y; Hashine K; Kasahara K; Karashima T
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1506-8. PubMed ID: 8854791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and prognostic significance of degenerative liver parenchyma damage].
    Sensing H; Kordon U
    Z Gesamte Inn Med; 1983 May; 38(9):39-41. PubMed ID: 6880312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatic lesions in acute cardiovascular failure in necropsy specimens].
    Jmelnitzky A; Castelletto R; Rondina A; Sidoti A; Apraiz M; Mincarelli JC; Toledo C; Albuquerque MM; Viñas D
    Acta Gastroenterol Latinoam; 1990; 20(2):81-8. PubMed ID: 2275312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.